April 7-8, 2017, Leuven, Belgium
This 2-day residential workshop will cover the molecular background of the common gynecological cancers, pathways involved in their carcinogenesis, potential targets for individualized treatment but also genetics and evolving therapeutics and their toxicity. Targeted treatments are already used in the clinic and expected to grow since most pharmaceutical companies have several targeted drugs in their pipeline, highlighting the need of good knowledge in clinical practice. Contents will be delivered by clinically oriented, multidisciplinary, plenary lectures.
This workshop also covers 3 parallel practical sessions on tumor immunology, and also interactive case presentations and group discussions.
• Cancer genetics
• Molecular pathways in ovarian cancer
• Molecular pathways in low-grade ovarian cancer
• Molecular pathways in endometrial cancer
• Molecular pathways in cervical cancer
• Targeting angiogenesis
• Targeting tyrosinkinases
• Targeting PARP
• Immunotherapy in gynecological malignancies
• Toxicities of immunotherapy and their management
• Why do studies of targeted treatment fail?
The aim of this 2-days workshop is to enhance the attendees´ ability to understand the molecular pathways of gynaecological malignancies. Attendees will also learn about the genetic disposition, potential role of cancer genetics in treatment decisions and counselling of patients. The workshop will review the mechanisms and current evidence of targeted treatment strategies and will help participants to recognise side effects and manage toxicities appropriately.
The workshop will be as interactive as possible allowing sufficient time for group discussions, also including a session where attendees are invited to present case scenarios from their clinical practice.
Workshop attendance is limited to 40 participants.
Only applicants who are active ESGO/ENGYO members and who have paid the course fee will be considered for participation.
Paid ESGO/ENYGO membership for 2017 is a mandatory condition for being considered.
Renew or join ESGO/ENYGO today!
Download the application form
Please note that a short CV is mandatory parts of the application.
Email the completed and signed application form with your CV to: firstname.lastname@example.org
Only applications sent by email will be considered.
Confirmations will be made on a first-come-first-served basis.
The fee includes:
• Admission to the workshop
• 2 nights accommodation in either two beds room shared with other participant (150 €) or single room (250 €), breakfast included
• Coffee breaks and lunch
• Dinner on Friday, April 7, 2017
Participants are expected to cover their own travel costs.
Payment details and cancellation conditions:
The course fee must be paid upon confirmation of attendance. The payment can be processed only by bank transfer; bank details will be available in the confirmation letter. The reservation can only be confirmed upon receipt of payment. In case of cancellation, the fee will be refunded, provided a written request is received by March 17, 2017. No refund can be made if the notice of cancellation is received after this date or in the case of a no-show.
For any queries please contact: email@example.com
KU Leuven and University Hospitals, Leuven, Belgium
Download the workshop Scientific programme
University Hospital, Leuven, Belgium
The European Society of Gynaecological Oncology (ESGO) is the leading European organisation with more than 2,500 professionals involved in treatment, care and research of gynaecologic cancers.
Get notified on all of ESGO’s news and activities.
European Society of Gyneacological Oncology (ESGO) | rue François-Versonnex 7, P.O.BOX 6053 | CH-1207 Genève, Switzerland